Swiss pharmaceuticals group Novartis tapped industry veteran and banking high-flier Jonathan Symonds to succeed Raymund Breu as chief financial officer, in a move welcomed by the market. Symonds, who spent eight years as CFO of UK-based rival Astrazeneca, will join Novartis on Sept. 1 from Goldman Sachs, where he is managing director of investment banking.
Ineos CEO Ineos calls on European politicians to save the chemical industry.
Compelling solutions through strategic partnerships
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
